274 results on '"Schmitz, Joy M."'
Search Results
2. Naltrexone plus bupropion reduces cigarette smoking in individuals with methamphetamine use disorder: A secondary analysis from the CTN ADAPT-2 trial
3. Behavioral therapies targeting reward mechanisms in substance use disorders
4. Trauma and Emotion Regulation: Associations with Depressive Symptoms and Cocaine Use among Treatment-seeking Adults
5. Contingency management plus acceptance and commitment therapy for initial cocaine abstinence: Results of a sequential multiple assignment randomized trial (SMART)
6. Biomarkers in Substance Use Disorder
7. An opioid-minimizing multimodal pain regimen reduces opioid exposure and pain in trauma-injured patients at high risk for opioid misuse: Secondary analysis from the mast trial
8. Naltrexone plus bupropion reduces cigarette smoking in individuals with methamphetamine use disorder: A secondary analysis from the CTN ADAPT-2 trial
9. Deficits in consummatory reward relate to severity of cocaine use
10. Late positive potential as a candidate biomarker of motivational relevance in substance use: Evidence from a meta-analysis
11. Feasibility of Exenatide, a GLP-1R Agonist, for Treating Cocaine Use Disorder: A Case Series Study
12. Comorbid alcohol use and post-traumatic stress disorders: Pharmacotherapy with aldehyde dehydrogenase 2 inhibitors versus current agents
13. 546 Using Contingency Management to Understand the Cardiovascular, Immune and Psychosocial Benefits of Reduced Cocaine Use: A Protocol for a Randomized Controlled Trial
14. Citalopram for treatment of cocaine use disorder: A Bayesian drop-the-loser randomized clinical trial
15. Posttraumatic stress symptom clusters differentially predict late positive potential to cocaine imagery cues in trauma-exposed adults with cocaine use disorder
16. Decreased cocaine demand following contingency management treatment
17. The effects of combination levodopa-ropinirole on cognitive improvement and treatment outcome in individuals with cocaine use disorder: A bayesian mediation analysis
18. Opioid Risk Tool, in-hospital opioid exposure, and opioid demand predict pain outcomes following traumatic injury.
19. Mindfulness as a predictor of cognitive-behavioral therapy outcomes in inner-city adults with posttraumatic stress and substance dependence
20. Reducing Tobacco Smoke Exposure in High-Risk Infants: A Randomized, Controlled Trial
21. Prenatal cocaine exposure and its influence on pediatric epigenetic clocks and epigenetic scores in humans
22. A meta‐analysis of electrophysiological biomarkers of reward and error monitoring in substance misuse
23. Regional differences in white matter integrity in stimulant use disorders: A meta-analysis of diffusion tensor imaging studies
24. A Novel, Integrated Cognitive-Behavioral Therapy for Co-Occurring Posttraumatic Stress and Substance Use Disorders: A Case Study
25. Cigarette smoking, type 2 diabetes mellitus, and glucagon-like peptide-1 receptor agonists as a potential treatment for smokers with diabetes: An integrative review
26. Using a data science approach to predict cocaine use frequency from depressive symptoms
27. Assessing Stage of Change and Harm Reduction Strategies for Synthetic Cannabinoid Use Among Individuals Experiencing Homelessness in Houston, Texas
28. White matter deficits in cocaine use disorder: convergent evidence from in vivo diffusion tensor imaging and ex vivo proteomic analysis
29. Mental Health Clinician Practices and Perspectives on Treating Adults with Co-Occurring Posttraumatic Stress and Substance Use Disorders
30. Initial development of a brief assessment of cocaine demand
31. Altered anterior cingulate cortex to hippocampus effective connectivity in response to drug cues in men with cocaine use disorder
32. Assessing cocaine motivational value: Comparison of brain reactivity bias toward cocaine cues and cocaine demand.
33. A preliminary longitudinal study of white matter alteration in cocaine use disorder subjects
34. Anhedonia Is Associated with Poorer Outcomes in Contingency Management for Cocaine Use Disorder
35. Pharmacological treatment of psychostimulant use disorders.
36. Types of Traumatic Experiences in Drug Overdose-Related Deaths: An Exploratory Latent Class Analysis
37. Assessing Stage of Change and Harm Reduction Strategies for Synthetic Cannabinoid Use Among Individuals Experiencing Homelessness in Houston, Texas
38. Electrophysiological responses to emotional and cocaine cues reveal individual neuroaffective profiles in cocaine users.
39. PPAR‐gamma agonist pioglitazone modifies craving intensity and brain white matter integrity in patients with primary cocaine use disorder: a double‐blind randomized controlled pilot trial
40. Nonjudgmental acceptance: Associations with substance-related cue reactivity in adults with substance use disorders and posttraumatic stress
41. Behavioral Mechanisms in Addiction
42. Increasing the Information Yield From Clinical Trials in Addictions
43. Trauma and Emotion Regulation: Associations with Depressive Symptoms and Cocaine Use among Treatment-seeking Adults
44. The potential of brain stimulation techniques for substance use disorder treatment
45. Distress tolerance: prospective associations with cognitive-behavioral therapy outcomes in adults with posttraumatic stress and substance use disorders
46. Targeting white matter neuroprotection as a relapse prevention strategy for treatment of cocaine use disorder: Design of a mechanism-focused randomized clinical trial
47. Prevalence and Correlates of Sex Selling and Sex Purchasing among Adults Seeking Treatment for Cocaine Use Disorder
48. Anti-saccade error rates as a measure of attentional bias in cocaine dependent subjects
49. The Role of Avoidance and Inflexibility in Characterizing Response to Contingency Management for Cocaine Use Disorders: A Secondary Profile Analysis
50. Prevalence of traumatic brain injury in cocaine-dependent research volunteers
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.